Abstract Heat shock proteins (Hsps) are induced by heat shock via heat shock factor proteins binding to heat shock elements in their promoters.
Introduction
Heat shock proteins (Hsps), originally described as proteins induced by heat, are defined by the presence of heat shock elements (HSE) in their promoters and induction by transcriptional regulatory proteins called heat shock factors (HSFs) [1] . It is now known that Hsps respond to a wide variety of brain injuries including ischemia and hemorrhage. In this short review, we examine the different functional roles of Hsp70, Hsp27, and Hsp32 (heme oxygenase, HO-1) and their potential as therapeutics. These three are highlighted because they have been the most studied, demonstrate the different functional roles of Hsps, and have different cellular localizations. Hsp70 is expressed at low levels in normal brain but is induced in all cells following ischemia, but particularly in neurons in the penumbra, and with ATP serves to refold misfolded or unfolded proteins ( Fig. 1 ) [1] . Hsp27 is expressed at low levels in normal brain and is induced primarily in astrocytes; in the absence of ATP, it binds misfolded proteins but does not refold them but may help solubilize misfolded proteins and prevent them from forming aggregates (Fig. 4) [2] . Hsp32, more commonly known as heme oxygenase-1 (HO-1), is induced following brain hemorrhage and brain ischemia mainly in microglia, and metabolizes heme to biliverdin, ferrous iron, and carbon monoxide (Fig. 6 ) [3] . This article is meant to be a very short synopsis, outlines updates, and briefly identifies evolving therapeutic potential of each Hsp.
Heat Shock Protein 70-Protein Refolding
The constitutive Hsp70 expressed in all cells is often referred to as Hsc70 or Hsp73. This protein is modestly inducible by heat shock and ischemia. It binds to all newly forming polypeptides on ribosomes in cells to keep them from folding inappropriately while they are being synthesized [4] . In addition, once fully synthesized, Hsc70 may help chaperone newly synthesized proteins to their intracellular targets, insert proteins into membranes, or help in folding proteins either alone or in conjunction with other protein complexes, for example, helping in mitochondrial biogenesis or helping in post-synaptic glycine receptor cluster formation [5] .
The inducible Hsp70 protein is also referred to as Hsp72 or simply Hsp70. In normal brain, it is barely detectable, but following heat shock, ischemia, and other injuries, it becomes the most abundant protein in the cell. This is because among several different functions to be discussed, it helps refold partially misfolded proteins or targets them for degradation (Fig. 1) .
HSF1, one of the heat shock factors, are bound in normal cells to Hsp70, Hsp90, and other proteins. With the appearance of misfolded proteins in cells, HSF1 disassociates from these chaperones, enters the nucleus, and binds to HSE in the promoter of Hsp70 and other Hsp70s (Fig. 1) . This results in increased transcription of hsp70 and eventually increased translation of more Hsp70 proteins (Fig. 1 ). Hsp70 protein, in conjunction with ATP, Hsp40, and Hsp90, then binds the misfolded proteins. This complex goes through several cycles of attempting to refold the proteins. This continues with binding of Huntingtin interacting protein (Hip) to the Nterminus of Hsp70 and Hsp70-Hsp90 organizing protein (Hop) to the C-terminus, and continues with successful refolding of the protein (Fig. 1) [6] . If refolding does not occur, then Bag-1 binds to the N-terminus of Hsp70, and the E3-ubiquitin ligase CHIP binds to the C-terminus of Hsp70. This complex then targets the misfolded protein to the proteasome where it is ubiquitinated and degraded. Thus, Hsp70 serves to triage damaged proteins either by refolding or degrading proteins [6] . Of interest, misfolded proteins directly activate Ire1 and initiate the unfolded protein response [7] . All of these responses help cells survive stress and improve outcomes following cerebral ischemia as discussed below.
Heat Shock Protein 70-Apoptosis
Inducible Hsp70 not only binds abnormally folded proteins but also has been shown to bind and regulate the functions of an increasing number of proteins involved in apoptosis (Fig. 2) . Hsp70, with its co-chaperone Hsp40, can stabilize FANCCan inhibitor of RNA-dependent protein kinase R-and inhibit tumor necrosis factor (TNF)-induced apoptosis. Hsp70 can also inhibit the assembly of the death-inducing signaling complex (DISC), inhibiting Fas-, TRAIL-, and TNF-induced apoptosis [8] . After TNF-induced DISC formation and caspase 8 activation, Hsp70 can inhibit BID activation and apoptosis [8] . Hsp70 can bind factors upstream of mitochondria, including blocking c-Jun NH(2)-terminal kinase (JNK)-induced release of BAD from mitochondria, blocking JNK activation of caspase 8, binding apoptosis signal-regulating kinase 1 (ASK1), and blocking MAPkinase-induced apoptosis [8] .
HSP70 can block Bcl-2-associated X protein (BAX) translocation, thus preventing mitochondrial outer membrane permeabilization. Hsp70 can bind Apaf-1 and prevent the formation of the apoptosome (Apaf-1, cytochrome C, and caspase 9) and activation of caspase 3 [8, 9] . Hsp70 can bind apoptosis inducible factor and prevent mitochondrial-mediated caspaseindependent apoptosis, and with Hsp40, it can form a complex with ICAD to prevent the activation of caspase-activated DNAase [8] . Hsp70 can stabilize Mcl-1 which prevents BAX activation and mitochondrial-mediated caspase-3-mediated apoptosis (Fig. 2) .
Though Hsp70 does not directly interact with caspases, we have shown that mutating the DEVD terminal sequence in Hsp70 to EEVD turns Hsp70 into a direct caspase 3 inhibitor [9] . It is notable that some of the above interactions appear to occur in some cell types and not others, and appear to be activated with certain types of pro-apoptotic stimuli and not others. Until it is clear what explains these differences, evidence for direct interactions of Hsp70 with a given pro-or anti-apoptotic molecule must be determined for each experimental paradigm.
Heat Shock Protein 70-Immune Pathways

Intracellular Effects of Hsp70 on Immune and Inflammatory Pathways
Hsp70 also has profound effects on various intracellular immune pathways and signaling. We have shown that Hsp70 interacts with the IκB kinase (IKK) complex to decrease NFκB signaling [10] , and others have shown that Hsp70 can decrease NFκB signaling by binding IκB, p65, p50, and cRel, and preventing TRAF activation of IKK [11] [12] [13] (Fig. 2) . Though the specific Hsp70-NFκB binding partner may be cell and stimulus specific, this interaction likely accounts for studies that show Hsp70 can decrease levels of TNF, IL1, matrix metallopeptidase 9 (MMP9), and other proinflammatory mediators that are regulated by NFκB.
Hsp70 has also been reported to decrease iNOS activation in glia, reduce nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activity, and increase superoxide in neutrophils, all of which would decrease free radicals [11] . Hsp70 downregulates the activity of MMP9 likely through NFκB. It can downregulate MMP2 as well, possibly through interactions of Hsp70 with STAT1, and may decrease MMP processing from inactive to active forms [12] . Overall, the intracellular effects of Hsp70 generally serve to suppress immune responses.
Extracellular Effects of Hsp70 on Immune Signaling
Hsp70 and other heat shock proteins appear to be either released by stressed cells as free soluble proteins or in detergent soluble membrane vesicles (exosomes) [8] . Once released, they can affect both the innate and adaptive immune systems, and generally appear to be "pro-inflammatory."
Hsp70 can stimulate toll-like receptor-2 (TLR-2), TLR4, and CD14 pathways on monocytes/macrophages, dendritic cells, and microglia, and activate intracellular NFκB, IRF, and Stat3 signaling [8] . Hsp70-peptide complexes can interact with macrophage and dendritic cells CD40, CD91, and LOX-1, and facilitate antigen presentation. In the adaptive immune system, Hsp70-peptide complexes can elicit CD8 + and CD4 + T cell responses [8, 11, 13] . Hsp70 activates cytolytic activity of natural killer cells via the C-type lectin receptor CD94 and the CD56 adhesion molecule [11] . Tailored Hsp-tumor peptides are being developed as tumor vaccines that facilitate killing of tumor cells via the adaptive immune system [14] . The pro-inflammatory properties of extracellular Hsp70 might affect its use in acute disorders like stroke and might be an even greater problem in chronic neurological diseases (see below). It is notable that an inverse correlation of Hsp70 protein levels in blood and atherosclerosis and risk of heart attack have been recently noted, and Hsp70 protein appears to be released into blood following myocardial infarction [11] .
Hsp70 Defines the Brain Ischemic Penumbra and is Neuroprotective
There is little to no inducible Hsp70 heat shock protein expressed in normal brain (Fig. 3a , left hemisphere; Fig. 3c ). However, following 10 min of focal cerebral ischemia, Hsp70 protein is induced in the middle cerebral artery (MCA) distribution 24 h later (Fig. 3a, right hemisphere) . Following a 1.5 h MCAO, there is infarction in much of the MCA distribution but with some Hsp70 expression at the watershed zone between the middle and anterior cerebral arteries (Fig. 3b, arrow) . For the 10-min occlusion, the penumbra represents the entire MCA distribution, and for the 2-h occlusion, the penumbra represented the border zone between the middle and anterior cerebral arteries. Hsp70 protein induction in the penumbra occurs primarily in neurons (Fig. 3d ) [15] . In areas of infarction, or areas adjacent to the infarction, Hsp70 protein can be expressed in microglia, astrocytes, and endothelial cells [15] . [20] .
Though the previous studies provide proof of principle, several recent studies have shown that modified Hsp70 proteins can protect against brain ischemia when administered intravenously. Intravenous TAT-Hsp70, a Hsp70 attached to a TAT motif to improve crossing the blood brain barrier, led to decreased infarct volumes, improved functional outcomes, and improved survival of neural progenitors in a mouse focal ischemia model [21] . We administered Fv-Hsp70, Hsp70 attached to a modified antibody to improve crossing the blood brain barrier, and showed decreased in infarct volumes and improved functional outcomes when given 2-3 h after stroke in rats [22] . Notably, Fv-Hsp70 appeared to cross the blood brain barrier in the ischemic hemisphere, but not the normal hemisphere, possibly improving on target effects [22] .
The intravenous administration of Hsp70, however, might be concerning since it might stimulate immune responses when given extracellularly and worsen injury-even if it protects when it goes inside the cells. Thus, other approaches might be better. Most recently, neural precursor cells transduced with TAT-Hsp70 have been shown to protect against experimental focal cerebral ischemia better than the precursor cells alone [23] . In addition, a small molecule inducer of Hsp70 given after stroke has also been shown to be protective, avoiding the problem of extracellular Hsp70 administration [24] . Given the mounting literature on Hsp70-induced neuroprotection, one wonders if it is not time to begin to consider this approach for human stroke trials. However, the issues of exactly how to modulate Hsp70 to avoid peripheral immune stimulation and promote brain neuroprotection have yet to be resolved in animal stroke models and require further investigation.
Heat Shock Protein 27-Unfolded and Misfolded Proteins
Hsp27, as typified by all members of the heat shock protein family, is inducible by heat shock, ischemia, and other cellular stressors via HSF actions on its promoter. Hsp27, however, is quite distinct from Hsp70 since it does not require ATP for its actions, and though it binds misfolded proteins, it does not appear to function in protein refolding per se [2] [6] [25] .
Dephosphorylation of Hsp27 favors large oligomer formation which binds to or forms "reservoirs" for unfolded or misfolded proteins [6] . The large oligomers appear to perform the "chaperone" functions attributed to Hsp27. Though the oligomers clearly bind unfolded and misfolded proteins, they do not appear to refold proteins. Instead, Hsp27 appears to hinder formation of misfolded protein aggregates and improve cell survival. Hsp27 associates with protein aggregates in many neurodegenerative diseases including Alzheimer's, Huntington's, amyotrophic lateral sclerosis, and Alexander's; overexpression of Hsp27 in animal models of these diseases decreases the formation of aggregates and often improves cell survival [2] [6, 26] [25] .
Hsp27 large oligomers also appear to interact with many cytoskeleton proteins including regulating actin polymerization and function of intermediate filaments (Fig.) [25] . It has also been proposed that the dynamic regulation of Hsp27 oligomers may regulate ubiquitination of specific target proteins with Hsp27 small oligomers favoring ubiquitination and proteasomal degradation of IκB, p27, and other specific proteins, whereas large Hsp27 oligomers may favor sumolylation and prevention of proteasomal degradation of these proteins (Fig. 4) [6] .
Heat Shock Protein 27-Role in Apoptosis
Hsp27 has been shown to decrease apoptotic cell death in a number of non-neural systems. It can diminish pro-caspase 9 Fig. 4 Hsp27 protein interacts with misfolded proteins and is phosphorylated to small oligomers that regulate apoptosis. Stetler et al. in the Chen group have shown that PKD phosphorylates Hsp27 which then binds ASK1, prevents cellular apoptosis, and protects the brain against focal cerebral ischemia [27] . P-Hsp27 binds cytochrome c and Akt/PKB in some cell types to modulate apoptosis. Large unphosphorylated Hsp27 oligomers bind misfolded proteins, help solubilize proteins, prevent protein aggregates and cellular inclusions, and improve cell survival. Hsp27 also modulates protein degradation via proteasome. This figure is modified from Stetler et al. [27] and Lanneau et al. [6] activation by inhibiting interaction with cytochrome c and formation of the apoptosome, and can inhibit the release of cytochrome c from the mitochondria (Fig. 4) [2] [6] . Hsp27 can directly interact with pro-caspase 3 and decrease its activation, and can indirectly suppress stress-induced Bax oligomerization and translocation to the mitochondria [2] . Hsp27 has also been reported to inactivate the pro-death JNK pathway and activate the pro-survival Akt/protein kinase B (PKB) pathway (Fig. 4) [2] . A caveat about many of these findings is that they have not always been replicated, leading to the conclusion that the specific anti-apoptotic actions of Hsp27 may differ in different cell types and with different stressors and injuries.
Heat Shock Protein 27-Role in Ischemic Brain
An elegant study by Stetler et al. from the Jun Chen group has recently defined the role of Hsp27 in neuroprotection in ischemic brain [27] . They showed that wild type Hsp27 and phosphorylatable Hsp27 (but not non-phosphorylatable Hsp27) protected the brain in a mouse focal cerebral ischemia model. They showed that Hsp27 phosphorylation by protein kinase D (PKD) at serine 15 and serine 82 was necessary for Hsp27-induced neuroprotection. They went on to show that phosphorylated Hsp27 bound to ASK1 and prevented ASK1 signaling via MKK4/7 to JNK and c-Jun which otherwise resulted in apoptosis (Fig. 4) [27] . This is a seminal study in neuroprotection afforded by Hsp27 since it provides several potential targets for therapy-administering P-Hsp27, stimulating PKD with small molecule inhibitors, or testing ASK1 inhibitors.
Role of Heat Shock Protein 27 in Neuroprotection
Hsp27 might be an attractive target for neuroprotection. Since it does not require ATP for its actions, it might work in ischemic tissue with low ATP levels. Of interest, Hsp27 is expressed at very low levels in normal brain, though is highly expressed in normal motor neurons, dorsal root ganglia neurons, medial preoptic neurons, and a subset of Purkinje cells [2] . Following ischemia, Hsp27 is induced almost entirely in astrocytes (Fig. 5) in the region of ischemia, and presumably identifies both the ischemic brain destined to die, as well as the ischemic penumbra. Given the role of Hsp27 in stabilizing the cytoskeleton, it is interesting that Hsp27 is expressed in both dorsal root ganglia neurons and motor neurons with very long processes, but not in cortical pyramidal neurons that also have very long processes. The reason why Hsp27 is fairly astrocyte specific is also not known, though it might interact with glial fibrillary acidic protein (GFAP) to stabilize the astrocyte cytoskeleton during periods of ischemic stress (Fig. 5 ).
Viral transfection of Hsp27 in vitro and in vivo has been shown to protect against brain ischemia and kainate-induced neuronal cell death [2] . As mentioned, infarct volumes are decreased in Hsp27 transgenic mice [28] but only with Hsp27 that can be phosphorylated by PKD [27] . Notably, this protection was achieved in mice where Hsp27 would have been expressed in all cell types. Hsp27 can also partially protect dorsal root ganglion neurons and motor neurons against different types of stressors/diseases; Hsp27 can decrease aggregate formation and improve outcomes in mouse neurodegenerative disease models including Huntington's, Parkinson's, and Alzheimer's diseases [2] . A direct test of Hsp27 in cerebral ischemia has also been performed where the PEP-1-Hsp27 fusion protein, designed to cross the BBB, was given intraperitoneally and protected hippocampal pyramidal neurons against death in the gerbil global ischemia model [29] . Hsp27 would appear to be an attractive target for neuroprotection in stroke because of its ATP independence, modulatory functions, and absence of any untoward effects that might aggravate ischemic brain injury.
Heme Oxygenase-1 (HO-1, Hsp 32)-Role in Heme Metabolism and Reactive Oxygen Species HO-1 metabolizes heme to biliverdin, carbon dioxide, and ferrous iron using NADPH as a cofactor (Fig. 6) . HO-1 is a heat shock protein family member since it has a HSF binding element in its promoter and is modestly inducible by heat shock [30] . However, HO-1 is induced by a large number of factors including heme itself, reactive oxygen species via Nrf2 (ARE elements in the HO-1 promoter), hypoxia inducible factor, NFκB, Jun/Fos, c/EBPa/Elk1, Jak/STAT, upstream stimulatory factor 1 (USF1)/USF2, and other transcriptional activators (Fig. 6) [3] . HO-1 in brain is induced primarily in microglial cells following hemorrhage (Fig. 7) , whereas the related non-inducible HO-2 protein that also metabolizes heme is expressed primarily in neurons.
HO-1 Can Mediate Cell Death or Cell Survival
The literature on the role of HO-1 in brain and various tissues is vast and often contradictory as to whether it promotes cell death or cell survival [30] . This likely relates to which cell types are being investigated and the nature of the specific stressor. Since HO-1 metabolizes heme to ferrous iron, the local ability of a cell or tissue to deal with iron will dictate the outcome. If hydrogen peroxide is abundant, this will promote the Fenton reaction and the formation of hydrogen peroxide, and cause oxidative damage (Fig. 6) . If ferrous iron is rapidly sequestered by ferritin and other binding proteins, then this harmful pathway will be circumvented. The protective actions of HO-1 include metabolizing heme which may be toxic on its own and formation of biliverdin which is then metabolized to bilirubin which is a potent anti-oxidant (Fig. 6) . Moreover, HO-1 metabolizes heme to CO which acts on cGMP to promote vasodilation (Fig. 6) . Thus, it is understandable that Fig. 6 Heme oxygenase (HO-1) metabolizes heme. The HO-1 promoter has elements for many transcription factors including Nrf2 and NFκB, and responds to heme. These induce HO-1 protein which then metabolizes heme to CO, ferrous ion, and biliverdin. CO mediates vasodilation via cGMP. Ferrous iron can be bound by transferrin and other iron binding proteins to prevent oxidative stress or be acted upon by hydrogen peroxide to produce hydroxyl ions to increase oxidative stress. Biliverdin is metabolized by biliverdin reductase to bilirubin which serves as an anti-oxidant [33] HO-1 could be protective or harmful in different cellular contexts and with different stressors.
Indeed, knocking out HO-1 worsens outcomes in animal models of ischemic stroke but improves outcomes in animal models of intracerebral hemorrhage (ICH) [31] [32] . Why HO-1 might protect following ischemia and worsen damage following ICH has not been resolved but could relate to acute iron overload in acute ICH. In addition, HO-1 appears to protect against EAE and specific brain infections [30] .
Role of HO-1 in Subarachnoid Hemorrhage
Bleeding into the subarachnoid space occurs following aneurysm rupture. To model this, we previously injected hemoglobin into the cisterna magna and found hemoglobin to slowly enter the brain parenchyma over many hours to a day (Fig. 7a) . Concurrent with this was the induction of HO-1 protein over 24 h (Fig. 7b) , with the HO-1 induction occurring almost exclusively in cerebral blood vessels (not shown) and in the brain microglia (Fig. 7b,c) [33] .
There is substantial evidence that the induction of HO-1 or the delivery of HO-1 to the brain or the subarachnoid space can protect against vasospasm that occurs following subarachnoid hemorrhage (SAH) [34] [35] [36] . The neuroprotection afforded by HO-1 could relate to the removal of heme and iron from around blood vessels and the production of bilirubin as an anti-oxidant. However, oxidation of bilirubin to BOXes has also been implicated in the production of vasospasm after SAH [37] , so that HO-1 might have protective as well as injurious effects following SAH [38] .
The possible protective role for HO-1 in SAH and ischemic stroke versus a possible harmful role in intracerebral hemorrhage certainly tempers enthusiasm for HO-1 as a therapeutic target in cerebrovascular disease. However, given the many known chemical inducers of HO-1 and the delay between SAH and onset of vasospasm, this could provide a novel approach to preventing ischemic neurological deficits post SAH.
